ImmuCell Corporation
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
ImmuCell Corporation is an animal health biologics company focused on products that support calf health and cattle productivity. The company develops, manufactures, and markets the First Defense product line, which is designed to help protect newborn calves against scours, a major cause of early-life illness in dairy and beef operations. ImmuCell also offers mastitis-related diagnostic products, including cow-side testing tools used to identify elevated somatic cell counts and help detect mastitis in dairy herds. Its current business is centered on practical, science-based solutions for livestock producers in the dairy and beef industries, with an emphasis on improving animal survivability, health, and day-to-day herd management. Headquartered in Portland, Maine, ImmuCell serves a specialized niche in the animal-health market through biologics, immunological products, and diagnostic assays.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Paul F. Olivier Te Boekhorst
- Employees
- 73
- Headquarters
- Portland, ME, United States
- Website
- immucell.com